At a glance
- Originator Abbott Laboratories
- Class Anthraquinones; Antibacterials
- Mechanism of Action Protein 30S ribosomal subunit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 24 Sep 1996 Discontinued-Preclinical for Bacterial infections in USA (Unknown route)
- 09 Jun 1995 New profile
- 09 Jun 1995 Preclinical development for Bacterial infections in USA (Unknown route)